Review Article - (2014) Volume 2, Issue 3
Chronic Lymphocytic Leukemia, Advantages of Monoclones?
- Viggo Jonsson1*, Haneef Awan1, Tom Borge Johannesen2 and Geir E Tjonnfjord1
- 1Department of Hematology, Rikshospital, Institute of Clinical Medicine, University of Oslo, Norway
- 2Norwegian Cancer Registry, Norway
*Corresponding Author:
Viggo Jonsson, Department of Hematology, Rikshospital, Institute of Clinical Medicine, University of Oslo, Postbox 4950 Nydalen NO 0424 Oslo, Norway, Tel: 004539680613
Email:
